356: Phase-II Study of Infliximab for the Prophylaxis of Acute Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
| dc.contributor.author | Hamadani, M. | |
| dc.contributor.author | Phillips, G. | |
| dc.contributor.author | Elder, P. | |
| dc.contributor.author | Jansak, B. | |
| dc.contributor.author | Blum, W. | |
| dc.contributor.author | Penza, S. | |
| dc.contributor.author | Lin, T.S. | |
| dc.contributor.author | Farag, S.S. | |
| dc.contributor.author | Devine, S.M. | |
| dc.contributor.department | Medicine, School of Medicine | en_US |
| dc.date.accessioned | 2021-01-20T19:47:09Z | |
| dc.date.available | 2021-01-20T19:47:09Z | |
| dc.date.issued | 2008-02-01 | |
| dc.eprint.version | Final published version | en_US |
| dc.identifier.citation | Hamadani, M., Phillips, G., Elder, P., Jansak, B., Blum, W., Penza, S., ... & Devine, S. M. (2008). 356: Phase-II Study of Infliximab for the Prophylaxis of Acute Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT). Biology of Blood and Marrow Transplantation, 14(2), 130-131. | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/24894 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | American Society for Blood and Marrow Transplantation | en_US |
| dc.relation.isversionof | 10.1016/j.bbmt.2007.12.366 | en_US |
| dc.relation.journal | Biology of Blood and Marrow Transplantation | en_US |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0 | * |
| dc.source | Publisher | en_US |
| dc.subject | Infliximab | en_US |
| dc.subject | Acute Graft-Versus-Host Disease | en_US |
| dc.subject | Prophylaxis | en_US |
| dc.title | 356: Phase-II Study of Infliximab for the Prophylaxis of Acute Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT) | en_US |
| dc.type | Article | en_US |